Generation Bio Co (GBIO)

Feb 21, 2025

Generation Bio stock hits 52-week low at $0.6 amid sharp decline - Investing.com

Feb 21, 2025

Feb 20, 2025

Spore.Bio raises €22 million to deploy a new generation of AI-based microbiology testing - EU-Startups

Feb 20, 2025

Feb 17, 2025

Layoff Tracker: Kojin Will Soon Close Its Doors, Affecting 25 Employees - BioSpace

Feb 17, 2025

Feb 12, 2025

Generation Bio stock hits 52-week low at $0.66 By Investing.com - Investing.com Nigeria

Feb 12, 2025

Feb 12, 2025

Generation Bio stock hits 52-week low at $0.66 - MSN

Feb 12, 2025

Feb 06, 2025

Insider Buying: Quinn Anthony G., Generation Bio Co [GBIO] Director invested 125,791 shares - Knox Daily

Feb 06, 2025

Feb 06, 2025

BBAI Stock Sees Surge of Approximately 95.33% in Last Five Days - Knox Daily

Feb 06, 2025

Feb 06, 2025

Insider Selling: Les Jason, Riot Platforms Inc [RIOT] CHIEF EXECUTIVE OFFICER divested 50,000 shares - Knox Daily

Feb 06, 2025

Feb 06, 2025

Biotech Executive Powerhouse: Ex-Generation Bio CFO Takes Dual Leadership Role at Rising ADC Developer Tubulis - StockTitan

Feb 06, 2025

Feb 04, 2025

Pioneering the next generation of bio-based polymers in partnership with London-listed Synthomer - University of York

Feb 04, 2025

Feb 03, 2025

Ratio Revelations: Generation Bio Co (GBIO)’s Financial Metrics in the Spotlight - The Dwinnex

Feb 03, 2025

Jan 24, 2025

Generation Bio (GBIO) Stock Price, News & Analysis - MarketBeat

Jan 24, 2025

Jan 23, 2025

3 US Penny Stocks With Market Cap Under $70M - Yahoo Finance

Jan 23, 2025

Jan 22, 2025

Generation Bio Co. (NASDAQ:GBIO) Shares Purchased by Barclays PLC - Defense World

Jan 22, 2025

Jan 20, 2025

Generation Bio chief scientific officer Matthew Stanton to leave role - MSN

Jan 20, 2025

Jan 17, 2025

Analysts Provide Insight Into Generation Bio Co’s (GBIO) Potential. - Stocks Register

Jan 17, 2025

Jan 16, 2025

Will Generation Bio (NASDAQ:GBIO) Spend Its Cash Wisely? - Yahoo Finance

Jan 16, 2025

Jan 16, 2025

Generation Bio Independent Director Acquires 131% More Stock - Yahoo Finance

Jan 16, 2025

Jan 15, 2025

Generation Bio Co. (NASDAQ:GBIO) Shares Sold by Jane Street Group LLC - Defense World

Jan 15, 2025

Jan 14, 2025

Generation Bio director Quinn Anthony buys $203k in shares By Investing.com - Investing.com South Africa

Jan 14, 2025

Jan 14, 2025

Generation Bio Co. (NASDAQ:GBIO) Director Anthony G. Quinn Purchases 125,791 Shares - MarketBeat

Jan 14, 2025

Jan 14, 2025

Anthony G. Quinn Purchases 85,000 Shares of Generation Bio Co. (NASDAQ:GBIO) Stock - MarketBeat

Jan 14, 2025

Jan 14, 2025

Generation Bio director Quinn Anthony buys $203k in shares - Investing.com

Jan 14, 2025

Jan 14, 2025

Seattle immunotherapy startup Umoja Biopharma raises $100M - GeekWire

Jan 14, 2025

Jan 10, 2025

Needham & Company LLC Issues Pessimistic Forecast for Generation Bio (NASDAQ:GBIO) Stock Price - Defense World

Jan 10, 2025

Jan 09, 2025

Generation Bio's SWOT analysis: ctLNP tech drives pivot to autoimmune stock - Investing.com Canada

Jan 09, 2025

Jan 09, 2025

Verdiva Bio, a New Clinical-Stage Cardiometabolic Company, Launches with Over $410M in Series A Financing to Advance Next-Generation Therapies - Business Wire

Jan 09, 2025

Jan 08, 2025

Finance Watch: Generation Bio, CytomX Right-Size Operations Ahead Of J.P. Morgan - News & Insights

Jan 08, 2025

Jan 08, 2025

Needham & Company LLC Lowers Generation Bio (NASDAQ:GBIO) Price Target to $8.00 - MarketBeat

Jan 08, 2025

Jan 07, 2025

Barclays PLC Boosts Position in Generation Bio Co. (NASDAQ:GBIO) - Defense World

Jan 07, 2025

Jan 07, 2025

Novo Nordisk partners with Variant Bio; Aviceda raises $207M in Series C - Endpoints News

Jan 07, 2025

Jan 07, 2025

Generation Bio Announces Executive Departures and Appointments - Defense World

Jan 07, 2025

Jan 07, 2025

Generation Bio Restructures Leadership and Focuses on siRNA - TipRanks

Jan 07, 2025

Jan 06, 2025

Generation Bio Co. Announces Executive Changes - Marketscreener.com

Jan 06, 2025

Jan 06, 2025

Generation Bio Co. to Apply ctLNP Delivery Technology to Develop siRNA Therapeutics for T Cell-Driven Autoimmune Diseases - Marketscreener.com

Jan 06, 2025